Amelioration of TMAO through probiotics and its potential role in atherosclerosis

Atherosclerosis is a major cause of mortalities and morbidities worldwide. It is associated with hyperlipidemia and inflammation, and become chronic by triggering metabolites in different metabolic pathways. Disturbance in the human gut microbiota is now considered a critical factor in the atheroscl...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Applied microbiology and biotechnology Jg. 103; H. 23-24; S. 9217 - 9228
Hauptverfasser:	Din, Ahmad Ud, Hassan, Adil, Zhu, Yuan, Yin, Tieying, Gregersen, Hans, Wang, Guixue
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Berlin/Heidelberg Springer Berlin Heidelberg 01.12.2019 Springer Springer Nature B.V
Schlagworte:	Animals Arteriosclerosis Atherosclerosis Atherosclerosis - physiopathology Atherosclerosis - prevention & control biochemical pathways Biomedical and Life Sciences Biosynthesis Biotechnology Canada Cardiovascular disease Carnitine Cholesterol Choline Diabetes Diet Flavin flavin-containing monooxygenase Health aspects Heart failure Humans Hyperlipidemia Immune system Inflammation Intestinal microflora intestinal microorganisms Lecithin Life Sciences Lipids Metabolic disorders Metabolic pathways Metabolites Metabolomics Methylamines - antagonists & inhibitors Methylamines - metabolism Mice Microbial Genetics and Genomics Microbiology Microbiomes Microbiota Microbiota (Symbiotic organisms) Microorganisms microRNA MicroRNAs Mini-Review miRNA Mortality oxidation Phosphatidylcholine phosphatidylcholines Prevention Probiotics Probiotics - therapeutic use Risk factors Trimethylamine Trimethylamine-N-oxide Type 2 diabetes Canada Gut microbiota TMAO Probiotics TMA lyases Atherosclerosis
ISSN:	0175-7598, 1432-0614, 1432-0614
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!